Fundz

Guardant Health, Inc. reported raising $320 Million in an initial SEC Form D filing, from an offering of $320 Million

PUBLIC · GHAug 09, 2017

Amount Raised

$320 Million

$320 Million sold, per SEC Form D (first sale Aug 9, 2017)

Round Type

Venture

Palo AltoBiotechnology Research

Quick answer

a United States-based clinical-stage oncology specialist raised $320 Million in a funding round, dated August 9, 2017. a United States-based clinical-stage oncology specialist is based in Palo Alto, California, United States.

How much did a United States-based clinical-stage oncology specialist raise?
a United States-based clinical-stage oncology specialist raised $320 Million in a funding round on August 9, 2017.
What does a United States-based clinical-stage oncology specialist do?
This oncology specialist is focused on developing innovative therapies for cancer treatment.
Where is a United States-based clinical-stage oncology specialist based and how big is it?
a United States-based clinical-stage oncology specialist is based in Palo Alto, California, United States.
Who are the decision-makers at a United States-based clinical-stage oncology specialist?
Fundz holds 3 contacts at a United States-based clinical-stage oncology specialist, including the Senior Director, IT & Global Infrastructure. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology Research around the same time

Companies in the same sectors as a United States-based clinical-stage oncology specialist that raised within 45 days of this round, from Fundz verified event records.

  • Daré Bioscience, Inc. raised $21M on July 28, 2017.
  • NewLeaf Symbiotics, Inc. raised $24M on July 10, 2017.

Who to call at a United States-based clinical-stage oncology specialist, and when

A new round usually means a United States-based clinical-stage oncology specialist is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day a United States-based clinical-stage oncology specialist raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at a United States-based clinical-stage oncology specialist, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at a United States-based clinical-stage oncology specialist. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

a United States-based clinical-stage oncology specialist

Location

505 Penobscot Dr.

Palo Alto, California, United States

About

This oncology specialist is focused on developing innovative therapies for cancer treatment. With a concentration on precision medicine, it targets specific cancer pathways to develop effective treatments. The company aims to advance the oncology pipeline in a rapidly evolving market.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment a United States-based clinical-stage oncology specialist raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsDave M., Senior Director, IT & Global Infrastruc… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for a United States-based clinical-stage oncology specialist's next move

See what Strategic adds

a United States-based clinical-stage oncology specialist raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.